Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents

H. Yang, C. Bueso-Ramos, C. Dinardo, M. R. Estecio, M. Davanlou, Q. R. Geng, Z. Fang, M. Nguyen, S. Pierce, Y. Wei, S. Parmar, J. Cortes, H. Kantarjian, G. Garcia-Manero

Research output: Contribution to journalArticlepeer-review

409 Scopus citations

Fingerprint

Dive into the research topics of 'Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents'. Together they form a unique fingerprint.

Medicine & Life Sciences